Qiagen NV (Qiagen NV) Other Long-Term Liabilities : $306 Mil (As of Dec. 2023)

View and export this data going back to 1996. Start your Free Trial

What is Qiagen NV Other Long-Term Liabilities?

Qiagen NV's other long-term liabilities for the quarter that ended in Dec. 2023 was $306 Mil.

Qiagen NV's quarterly other long-term liabilities declined from Jun. 2023 ($357 Mil) to Sep. 2023 ($306 Mil) but then increased from Sep. 2023 ($306 Mil) to Dec. 2023 ($306 Mil).

Qiagen NV's annual other long-term liabilities declined from Dec. 2021 ($401 Mil) to Dec. 2022 ($357 Mil) and declined from Dec. 2022 ($357 Mil) to Dec. 2023 ($306 Mil).

Qiagen NV Other Long-Term Liabilities Historical Data

The historical data trend for Qiagen NV's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qiagen NV Other Long-Term Liabilities Chart

Qiagen NV Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long-Term Liabilities

Get a 7-Day Free Trial

Qiagen NV Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Qiagen NV Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Qiagen NV Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Qiagen NV's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Qiagen NV (Qiagen NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Qiagen NV (NYSE:QGEN) » Definitions » Other Long-Term Liabilities

Comparable Companies

EXAS NTRA CRL MEDP RVTY RDNT DGX SHC NEOG GH TMO DHR IQV XSWX:LONN IDXX A MTD ICLR ILMN WAT

Traded in Other Exchanges

1QGEN:Italy QIAd:UK 0RLT:UK QIA:Germany QIA:Germany QIA:Germany QIA:Germany QGEN:Austria

Address

Hulsterweg 82, Venlo, LI, NLD, 5912 PL

Website

https://www.qiagen.com

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (over 45% of 2022 sales), followed by EMEA (nearly 35%), and Asia-Pacific (nearly 20%).

Executives